BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 6956782)

  • 1. Analysis of human leukemia/lymphoma cell lines with monoclonal antibodies BA-1, BA-2 and BA-3.
    LeBien T; Kersey J; Nakazawa S; Minato K; Minowada J
    Leuk Res; 1982; 6(3):299-305. PubMed ID: 6956782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of monoclonal antibodies and immuno-scanning electron microscopy for the positive identification of human leukemic cells.
    Gamliel H; Gurfel D; Polliack A
    J Clin Immunol; 1983 Oct; 3(4):399-407. PubMed ID: 6581172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivity of monoclonal anti-K 562 antibodies with cells of leukemia- and lymphoma-patients.
    Hering S; Böttger V; Baryschnikow AJ; Micheel B
    Arch Geschwulstforsch; 1985; 55(1):9-16. PubMed ID: 3885896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the BLA antigen, defined by the monoclonal 38.13 antibody, on Burkitt lymphoma lines, lymphoblastoid cell lines, their hybrids and other B-cell lymphomas and leukemias.
    Klein G; Manneborg-Sandlund A; Ehlin-Henriksson B; Godal T; Wiels J; Tursz T
    Int J Cancer; 1983 May; 31(5):535-42. PubMed ID: 6303966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A unique cell surface antigen identifying lymphoid malignancies of B cell origin.
    Nadler LM; Ritz J; Hardy R; Pesando JM; Schlossman SF; Stashenko P
    J Clin Invest; 1981 Jan; 67(1):134-40. PubMed ID: 6969730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A monoclonal antibody GR2110 reactive with a P24 antigen present in a subgroup of acute lymphoid leukemias.
    Gomez-Morales M; Ruiz-Cabello F; López MA; Collado A; Cabrera T; San Miguel J; Garrido F
    Hybridoma; 1985; 4(4):369-78. PubMed ID: 3864743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivity pattern of 'myeloid monoclonal antibodies' with emphasis on MCS-2.
    Drexler HG; Sagawa K; Menon M; Minowada J
    Leuk Res; 1986; 10(1):17-23. PubMed ID: 3456072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of monoclonal antibodies, morphology, and cytochemistry to probe the cellular heterogeneity of acute leukemia and lymphoma.
    LeBien TW; McKenna RW; Abramson CS; Gajl-Peczalska KJ; Nesbit ME; Coccia PF; Bloomfield CD; Brunning RD; Kersey JH
    Cancer Res; 1981 Nov; 41(11 Pt 2):4776-80. PubMed ID: 6945905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody affinity may influence antigenic modulation of the common acute lymphoblastic leukemia antigen in vitro.
    Lebien TW; Boué DR; Bradley JG; Kersey JH
    J Immunol; 1982 Nov; 129(5):2287-92. PubMed ID: 6956632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphonuclear neutrophils express the common acute lymphoblastic leukemia antigen.
    Cossman J; Neckers LM; Leonard WJ; Greene WC
    J Exp Med; 1983 Mar; 157(3):1064-9. PubMed ID: 6220104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a monoclonal anti-GP70 antibody and characterization of its reactivity with various human cell lines and cells from leukemia-lymphoma patients.
    Gazitt Y; Sammar M; Treves AJ; Manny N; Gurfel D; Polliack A
    Immunol Lett; 1986 Mar; 12(2-3):101-8. PubMed ID: 3522412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic classification of leukemia and lymphoma.
    Foon KA; Todd RF
    Blood; 1986 Jul; 68(1):1-31. PubMed ID: 2941082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EBV infections in Brazil. I. Occurrence in normal persons, in lymphomas and in leukemias.
    Carvalho RP; Evans AS; Frost P; Dalldorf G; Camargo ME; Jamra M
    Int J Cancer; 1973 Jan; 11(1):191-201. PubMed ID: 4364322
    [No Abstract]   [Full Text] [Related]  

  • 14. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
    Raso V; Ritz J; Basala M; Schlossman SF
    Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of cell surface membrane antigens common to both human neuroblastoma and leukemia-lymphoma cell lines by a panel of 38 monoclonal antibodies.
    Sugimoto T; Tatsumi E; Kemshead JT; Helson L; Green AA; Minowada J
    J Natl Cancer Inst; 1984 Jul; 73(1):51-7. PubMed ID: 6610792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of antigens defined by OKB monoclonal antibodies on benign and malignant lymphoid cells and on nonlymphoid tissues.
    Knowles DM; Tolidjian B; Marboe CC; Mittler RS; Talle MA; Goldstein G
    Blood; 1984 Apr; 63(4):886-96. PubMed ID: 6423012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective expression of the common acute lymphoblastic leukemia (gp 100) antigen on immature lymphoid cells and their malignant counterparts.
    Greaves MF; Hariri G; Newman RA; Sutherland DR; Ritter MA; Ritz J
    Blood; 1983 Apr; 61(4):628-39. PubMed ID: 6338969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant human B cells express two populations of p24 surface antigens.
    Pesando JM; Hoffman P; Conrad T
    J Immunol; 1986 Apr; 136(7):2709-14. PubMed ID: 3485154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune complex disease in the kidneys of lymphoma-leukemia patients: the presence of an oncornavirus-related antigen.
    Sutherland JC; Mardiney MR
    J Natl Cancer Inst; 1973 Mar; 50(3):633-44. PubMed ID: 4267705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.